Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Jansen

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 8, 2022
HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019Uwe Koppe, Janna Seifried, Ulrich Marcus, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 17, 2017
Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014Sandra Dudareva-Vizule, Karin Haar, Andrea Sailer, et al.
BMC Infectious Diseases|June 20, 2024
Clinically inapparent mpox virus (MPXV) infections among clients of three anonymous Community Based Voluntary Counselling and Testing centres in Berlin, Germany, 2022-2023Uwe Koppe, Klaus Jansen, Axel Jeremias Schmidt, et al.
BMC Infectious Diseases|January 19, 2018
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistanceSusanne Buder, Sandra Dudareva, Klaus Jansen, et al.
BMC Infectious Diseases|August 14, 2013
Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysisKlaus Jansen, Burkhard Haastert, Claudia Michalik, et al.
BMC Infectious Diseases|July 18, 2020
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in GermanyRegina Selb, Klaus Jansen, Matthias Eckardt, et al.
BMC Infectious Diseases|February 9, 2020
STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in GermanyKlaus Jansen, Gyde Steffen, Anja Potthoff, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Rapid spread of MPXV clade Ib with high genetic relatedness among men who have sex with men, Berlin, Germany, week 50 2025 up to week 10 2026Alexander Bartel, Klaus Jansen, Ronja Boberg, et al.
International Journal of STD & AIDS|November 24, 2025
The end of the gold standard in syphilis diagnostics - A comparison of alternative screening test methodsJuliane Fazio, Marie-Christin Höppner, Kristin Maria Meyer-Schlinkmann, et al.
Plos One|May 3, 2014
First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter studyFabia Zu Knyphausen, Ramona Scheufele, Claudia Kücherer, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 8, 2022
HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019Uwe Koppe, Janna Seifried, Ulrich Marcus, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 17, 2017
Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014Sandra Dudareva-Vizule, Karin Haar, Andrea Sailer, et al.
BMC Infectious Diseases|June 20, 2024
Clinically inapparent mpox virus (MPXV) infections among clients of three anonymous Community Based Voluntary Counselling and Testing centres in Berlin, Germany, 2022-2023Uwe Koppe, Klaus Jansen, Axel Jeremias Schmidt, et al.
BMC Infectious Diseases|January 19, 2018
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistanceSusanne Buder, Sandra Dudareva, Klaus Jansen, et al.
BMC Infectious Diseases|August 14, 2013
Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysisKlaus Jansen, Burkhard Haastert, Claudia Michalik, et al.
BMC Infectious Diseases|July 18, 2020
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in GermanyRegina Selb, Klaus Jansen, Matthias Eckardt, et al.
BMC Infectious Diseases|February 9, 2020
STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in GermanyKlaus Jansen, Gyde Steffen, Anja Potthoff, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Rapid spread of MPXV clade Ib with high genetic relatedness among men who have sex with men, Berlin, Germany, week 50 2025 up to week 10 2026Alexander Bartel, Klaus Jansen, Ronja Boberg, et al.
International Journal of STD & AIDS|November 24, 2025
The end of the gold standard in syphilis diagnostics - A comparison of alternative screening test methodsJuliane Fazio, Marie-Christin Höppner, Kristin Maria Meyer-Schlinkmann, et al.
Plos One|May 3, 2014
First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter studyFabia Zu Knyphausen, Ramona Scheufele, Claudia Kücherer, et al.
Pageof 6